Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Stroma
100%
Lymph Node Metastasis
100%
Distant Metastasis
100%
Colorectal Carcinoma
100%
Tissue Inhibitor of Metalloproteinase 1
100%
Metastatic Carcinoma
30%
Messenger RNA
30%
Neoplasm
20%
Liver Metastasis
20%
Cancer Cell
10%
Protein Degradation
10%
Mucosa
10%
Liver Injury
10%
Cancer Staging
10%
Tumor Invasion
10%
Northern Blotting
10%
Matrix Metalloproteinase
10%
Metalloprotease Inhibitor
10%
Fibroblast
10%
In Situ Hybridization
10%
Keyphrases
Colorectal Cancer
100%
Lymph Node Metastasis
100%
Distant Metastasis
100%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
100%
MRNA Level
18%
Metastasis
18%
Liver Metastasis
18%
Human Colorectal Cancer
18%
Fold Increase
9%
In Cancer
9%
Tumor Metastasis
9%
Spindle
9%
Cancer Cells
9%
Advanced Colorectal Cancer
9%
Proteolytic Activity
9%
In Situ Hybridization
9%
Cellular RNA
9%
Tumor Size
9%
Tumor Stroma
9%
RNA Expression
9%
Tumor Invasion
9%
RNA Standards
9%
Matrix metalloproteinase-2 (MMP-2)
9%
Northern Blot Hybridization
9%
Fibroblast-like
9%
Metastatic Liver Lesions
9%
Primary Colorectal Cancer
9%
Colorectal Cancer Staging
9%
Growth-promoting Function
9%
Pharmacology, Toxicology and Pharmaceutical Science
Lymph Node Metastasis
100%
Colorectal Carcinoma
100%
Tissue Inhibitor of Metalloproteinase 1
100%
Distant Metastasis
100%
Messenger RNA
30%
Neoplasm
20%
Liver Metastasis
20%
Malignant Neoplasm
10%
Liver Injury
10%
Cancer Staging
10%
Tumor Invasion
10%
Matrix Metalloproteinase
10%
Tissue Inhibitor of Metalloproteinase
10%
Immunology and Microbiology
Lymph Node
100%
Stroma
100%
Ribonucleic Acid
100%
Colorectal Carcinoma
100%
Protein Degradation
11%
Cancer Cell
11%
Northern Blotting
11%
Tumor Volume
11%
Cancer Staging
11%
Mucosa
11%
Fibroblast
11%
In Situ Hybridization
11%
Biochemistry, Genetics and Molecular Biology
RNA
100%
Metalloprotease Inhibitor
100%
Messenger RNA
27%
Cancer Cell
9%
Protein Catabolism
9%
Northern Blotting
9%
Tumor Volume
9%
Matrix Metalloproteinase
9%
Mucosa
9%
Cancer Staging
9%
Fibroblast
9%
In Situ Hybridization
9%